December 30, 2021 / by Allison Sessa / Alerts, Pharmacy Announcements
Date: December 29, 2021 To: All Pharmacies Provider Alert Type: Informational From: Health Plan of San Joaquin Subject: Medi-Cal Rx PBM Information Business: Medi-Cal Beginning January 1, 2022, Health Plan of San Joaquin pharmacy benefits will be transitioned to and administered by the new California State agency, Medi-Cal Rx. Medi Cal Rx is responsible for [...]
Read more
Submitting Quality Data to the California Immunization Registry (CAIR2) – May 2022
May 26, 2022 / by Viktoriya Sosa / Pharmacy Announcements
The California Immunization Registry (CAIR2) is a secure web-based platform that allows providers and organizations to track patient immunization and tuberculosis records. The CAIR2 aims to improve vaccination rates, minimize missed immunization opportunities, and prevent administration of duplicate immunizations. Patient-specific and aggregate reports in the CAIR2 system allow for accurate assessment of vaccination coverage rates [...]Read more
Professional Organizations Push for Recall of Buprenorphine Dental Warning – February 2022
March 2, 2022 / by Allison Sessa / Pharmacy Announcements
On January 24, 2022, a letter from the American Society of Addiction Medicine (ASAM) and ten other health professional associations called for the FDA to immediately and fully retract their Drug Safety Communication on dental problems associated with buprenorphine, which was based on 305 reported cases of dental problems since 2002. The authors note that nearly 2.4 [...]Read more
Improving the Quality of Care: Legislative Impact on the Use of Naloxone
January 3, 2022 / by Allison Sessa / Pharmacy Announcements
Date: January 3, 2022 To: All Pharmacies Provider Alert Type: Informational/Educational From: Health Plan of San Joaquin Subject: Improving the Quality of Care: Legislative Impact on the Use of Naloxone Business: Medi-Cal Download Attachment PDFExcelWordZipPowerpointImageMP3CloseBy DateBy NameBy TypeCloseShow all files Jan 3rd, 2022 Improving the Quality of Care-Legislative Impact on the Use of Naloxone Next [...]Read more
Medi-Cal Rx PBM Information
December 30, 2021 / by Allison Sessa / Alerts, Pharmacy Announcements
Date: December 29, 2021 To: All Pharmacies Provider Alert Type: Informational From: Health Plan of San Joaquin Subject: Medi-Cal Rx PBM Information Business: Medi-Cal Beginning January 1, 2022, Health Plan of San Joaquin pharmacy benefits will be transitioned to and administered by the new California State agency, Medi-Cal Rx. Medi Cal Rx is responsible for [...]Read more
Irbesartan & Irbesartan/Hctz Recall – IMMEDIATE ACTION NEEDED
October 21, 2021 / by Allison Sessa / Alerts, Pharmacy Announcements
Date: October 21, 2021 To: Health Plan of San Joaquin (HPSJ) Pharmacies and Providers & Practices From: HPSJ Pharmacy Department Subject: Irbesartan & Irbesartan/Hctz Recall - IMMEDIATE ACTION NEEDED Business: Medi-Cal Managed Care We are sending this alert because you may have one or more patients who filled a prescription for Irbesartan Tablets or Irbesartan/Hydrochlorothiazide [...]Read more
2021 Immunization Updates: COVID-19, Influenza, and Meningococcal Disease
October 20, 2021 / by Allison Sessa / Alerts, Pharmacy Announcements
Each year, the California Medi-Cal Drug Use Review (DUR) program issues an annual summary of updates on immunization guidelines, products, and/or research in collaboration with the California Department of Public Health (CDPH) Immunization Branch. For reference, the recommended immunization schedules for 2021 in the United States can be accessed on the Centers for Disease Control […]
Read more
Formulary Update – Effective November 30th, 2021
September 22, 2021 / by Allison Sessa / Alerts, Pharmacy Announcements
Date: September 22 To: Health Plan of San Joaquin (HPSJ) Physicians, Providers, and Pharmacies From: Health Plan of San Joaquin Pharmacy and Therapeutics Committee Subject: Formulary Update - Effective November 30th, 2021 Business: Medi-Cal Managed Care Effective 11/30/2021, the Pharmacy and Therapeutics Committee has approved the following changes. Additions to the Formulary Eluxadoline (Viberzi) 75 [...]Read more
Updated: Voluntary Recall of Varenicline (Chantix) Lots Containing Nitrosamine
September 20, 2021 / by Allison Sessa / Pharmacy Announcements
UPDATED: Drug Safety Communication: Voluntary Recall of Varenicline (Chantix) Due to Nitrosamine Varenicline is a prescription medicine that is used to help adults quit smoking. On September 17, 2021, the U.S. Food and Drug Administration (FDA) announced a voluntary manufacturer recall of all lots of varenicline (Chantix) 0.5 mg and 1 mg tablets due to […]
Read more
FDA Requests Removal of Pregnancy Contraindication for Statins
September 17, 2021 / by Allison Sessa / Pharmacy Announcements
Statins are a class of prescription medications that act by inhibiting 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase, an enzyme in the liver that is responsible for making cholesterol. Statins are commonly used for preventing and treating the build-up of fats, cholesterol, and other substances in and on the artery walls (atherosclerosis) and have been shown to […]
Read more
Chantix Products Recall – IMMEDIATE ACTION NEEDED
July 28, 2021 / by Allison Sessa / Alerts, Pharmacy Announcements
Date: July 28, 2021 To: Health Plan of San Joaquin (HPSJ) Pharmacies and Providers From: HPSJ Pharmacy Department Subject: Chantix Products Recall – IMMEDIATE ACTION NEEDED Business: Medi-Cal Managed Care We are sending this alert because one or more of your patient(s) may have filled a prescription for Chantix Tablets within the last six months [...]Read more